Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm

International Journal of Infectious Diseases

Alimuddin Zumla¹  Martin Rao²  Ernest Dodoo²  Markus Maeurer²  Davide Valentini² 

[1] Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK;Division of Therapeutic Immunology (TIM), Department of Laboratory Medicine (LABMED), Karolinska Institutet, Stockholm, Sweden;

关键词: Anti-PD-1;    Anti-PD-L1;    T-cells;    Cancer;    Infectious disease;    Host-directed therapy;   

DOI  :  10.1016/j.ijid.2017.01.028

来源: DOAJ

【 授权许可】

Unknown